Elena Favaro - Publications

Affiliations: 
2009-2013 University of Oxford, Oxford, United Kingdom 

11/23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Bensaad K, Favaro E, Lewis CA, Peck B, Lord S, Collins JM, Pinnick KE, Wigfield S, Buffa FM, Li JL, Zhang Q, Wakelam MJ, Karpe F, Schulze A, Harris AL. Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation. Cell Reports. 9: 349-65. PMID 25263561 DOI: 10.1016/j.celrep.2014.08.056  0.622
2014 Zois CE, Favaro E, Harris AL. Glycogen metabolism in cancer. Biochemical Pharmacology. 92: 3-11. PMID 25219323 DOI: 10.1016/j.bcp.2014.09.001  0.514
2014 Gómez-Maldonado L, Tiana M, Roche O, Prado-Cabrero A, Jensen L, Fernandez-Barral A, Guijarro-Muñoz I, Favaro E, Moreno-Bueno G, Sanz L, Aragones J, Harris A, Volpert O, Jimenez B, Del Peso L. EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination Oncogene. 34: 2609-2620. PMID 25023702 DOI: 10.1038/Onc.2014.200  0.311
2014 Jiang H, Favaro E, Goulbourne CN, Rakowska PD, Hughes GM, Ryadnov MG, Fong LG, Young SG, Ferguson DJ, Harris AL, Grovenor CR. Stable isotope imaging of biological samples with high resolution secondary ion mass spectrometry and complementary techniques. Methods (San Diego, Calif.). 68: 317-24. PMID 24556558 DOI: 10.1016/j.ymeth.2014.02.012  0.318
2013 Favaro E, Harris AL. Targeting glycogen metabolism: a novel strategy to inhibit cancer cell growth? Oncotarget. 4: 3-4. PMID 23448808  0.508
2012 Favaro E, Bensaad K, Chong MG, Tennant DA, Ferguson DJ, Snell C, Steers G, Turley H, Li JL, Günther UL, Buffa FM, McIntyre A, Harris AL. Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells. Cell Metabolism. 16: 751-64. PMID 23177934 DOI: 10.1016/j.cmet.2012.10.017  0.683
2012 Fabian C, Koetz L, Favaro E, Indraccolo S, Mueller-Klieser W, Sattler UG. Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts. The Febs Journal. 279: 882-91. PMID 22240028 DOI: 10.1111/j.1742-4658.2012.08479.x  0.363
2011 Favaro E, Lord S, Harris AL, Buffa FM. Gene expression and hypoxia in breast cancer. Genome Medicine. 3: 55. PMID 21875443 DOI: 10.1186/gm271  0.665
2010 Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, Vojnovic B, Pires das Neves R, Glazer P, Iborra F, Ivan M, et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. Plos One. 5: e10345. PMID 20436681 DOI: 10.1371/Journal.Pone.0010345  0.474
2009 Pistollato F, Chen HL, Rood BR, Zhang HZ, D'Avella D, Denaro L, Gardiman M, te Kronnie G, Schwartz PH, Favaro E, Indraccolo S, Basso G, Panchision DM. Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma. Stem Cells (Dayton, Ohio). 27: 7-17. PMID 18832593 DOI: 10.1634/Stemcells.2008-0402  0.303
2008 Favaro E, Nardo G, Persano L, Masiero M, Moserle L, Zamarchi R, Rossi E, Esposito G, Plebani M, Sattler U, Mann T, Mueller-Klieser W, Ciminale V, Amadori A, Indraccolo S. Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death. The American Journal of Pathology. 173: 1186-201. PMID 18772337 DOI: 10.2353/ajpath.2008.071183  0.356
Low-probability matches (unlikely to be authored by this person)
2011 Nardo G, Favaro E, Curtarello M, Moserle L, Zulato E, Persano L, Rossi E, Esposito G, Crescenzi M, Casanovas O, Sattler U, Mueller-Klieser W, Biesalski B, Thews O, Canese R, et al. Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralization Cancer Research. 71: 4214-4225. PMID 21546569 DOI: 10.1158/0008-5472.Can-11-0242  0.27
2008 Favaro E, Amadori A, Indraccolo S. Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 116: 648-59. PMID 18834409 DOI: 10.1111/j.1600-0463.2008.01025.x  0.269
2014 Jiang H, Favaro E, Goulbourne CN, Ferguson DJ, Young SG, Harris AL, Grovenor CR. Quantitatively Imaging Stable Isotopes at Subcellular Level with Correlative Electron Microscopy and Nanosims Analysis Biophysical Journal. 106: 597a-598a. DOI: 10.1016/J.BPJ.2013.11.3309  0.267
2009 Indraccolo S, Minuzzo S, Masiero M, Pusceddu I, Persano L, Moserle L, Reboldi A, Favaro E, Mecarozzi M, Di Mario G, Screpanti I, Ponzoni M, Doglioni C, Amadori A. Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy. Cancer Research. 69: 1314-23. PMID 19208840 DOI: 10.1158/0008-5472.CAN-08-2791  0.213
2007 Masiero M, Nardo G, Indraccolo S, Favaro E. RNA interference: implications for cancer treatment. Molecular Aspects of Medicine. 28: 143-66. PMID 17307250 DOI: 10.1016/j.mam.2006.12.004  0.194
2007 Favaro E, Indraccolo S. Gene therapy of cancer in the clinic: good news in sight from Asia? Current Opinion in Molecular Therapeutics. 9: 477-82. PMID 17932811  0.133
2020 Hämälistö S, Stahl JL, Favaro E, Yang Q, Liu B, Christoffersen L, Loos B, Guasch Boldú C, Joyce JA, Reinheckel T, Barisic M, Jäättelä M. Spatially and temporally defined lysosomal leakage facilitates mitotic chromosome segregation. Nature Communications. 11: 229. PMID 31932607 DOI: 10.1038/s41467-019-14009-0  0.106
2016 Corcelle-Termeau E, Vindeløv SD, Hämälistö S, Mograbi B, Keldsbo A, Bräsen JH, Favaro E, Adam D, Szyniarowski P, Hofman P, Krautwald S, Farkas T, Petersen NH, Rohde M, Linkermann A, et al. Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closure. Autophagy. 1-17. PMID 27070082 DOI: 10.1080/15548627.2016.1159378  0.099
2023 Izutsu K, Kumode T, Yuda J, Nagai H, Mishima Y, Suehiro Y, Yamamoto K, Fujisaki T, Ishitsuka K, Ishizawa K, Ikezoe T, Nishikori M, Akahane D, Fujita J, Dinh M, ... ... Favaro E, et al. Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma. Cancer Science. PMID 37921363 DOI: 10.1111/cas.15996  0.077
2006 Indraccolo S, Favaro E, Amadori A. Dormant tumors awaken by a short-term angiogenic burst: the spike hypothesis. Cell Cycle (Georgetown, Tex.). 5: 1751-5. PMID 16861908 DOI: 10.4161/cc.5.16.2985  0.071
2022 Lane W, Favaro E, Jódar E, Kelkar P, Oviedo A, Sivarathinasami R, Senior PA, Sesti G, Franek E. Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. 13: 761-774. PMID 35290624 DOI: 10.1007/s13300-022-01213-3  0.01
2020 Lane WS, Favaro E, Rathor N, Jang HC, Kjærsgaard MIS, Oviedo A, Rose L, Senior P, Sesti G, Soto Gonzalez A, Franek E. A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9). Diabetes Care. PMID 32209647 DOI: 10.2337/dc19-2232  0.01
Hide low-probability matches.